Our study indicates that TNF-α signaling is implicated in cardiac insulin sensitivity regulation, further emphasizing promising therapeutic targets for disease conditions with chronic low-grade inflammation, such as metabolic cardiovascular syndrome. The gene discussed is INS; the disease is metabolic syndrome.